Detalles de la búsqueda
1.
Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia.
Haematologica
; 104(3): 576-586, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262568
2.
Dual targeting of MCL1 and NOXA as effective strategy for treatment of mantle cell lymphoma.
Br J Haematol
; 177(4): 557-561, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28295185
3.
The phosphatidylinositol-3-kinase inhibitor NVP-BKM120 overcomes resistance signals derived from microenvironment by regulating the Akt/FoxO3a/Bim axis in chronic lymphocytic leukemia cells.
Haematologica
; 98(11): 1739-47, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23850807
4.
The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 23(11): 2831-2841, 2017 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27903679
5.
CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia.
Oncotarget
; 7(5): 5507-20, 2016 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26701728
6.
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia.
Oncotarget
; 6(26): 22734-49, 2015 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26068951
7.
Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.
Oncotarget
; 6(25): 21159-72, 2015 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26110568
8.
Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma.
Oncotarget
; 5(16): 6788-800, 2014 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25216518
9.
Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma.
Oncotarget
; 5(3): 726-39, 2014 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24519895
10.
Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma.
Clin Cancer Res
; 19(3): 586-97, 2013 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23231952
Resultados
1 -
10
de 10
1
Próxima >
>>